Collard Craig A bought HRTX
January 30, 2026 · Form 4 insider transaction
Collard Craig A bought 800,337 shares of Heron Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
800,337
Price
$0.00
Total value
N/A
InsiderCollard Craig A
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2026
Filing dateFebruary 3, 2026
Shares owned after800,337
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.; On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein.